Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Myomo (NYSE American: MYO), a wearable medical robotics company focused on neurological disorders and upper-limb paralysis, has announced its participation in the 24th Annual Needham Virtual Healthcare Conference.

Company executives Paul Gudonis (President and CEO) and David Henry (CFO) will deliver a presentation on Thursday April 10th at 3:00 p.m. ET. The presentation will be available via live webcast and will subsequently be archived in the Investors section of Myomo's website. During the conference, which runs from April 7th to April 10th, the executives will also conduct one-on-one meetings with registered investors.

BURLINGTON, Mass.--(BUSINESS WIRE)-- Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, president and chief executive officer and David Henry, chief financial officer, will present at the 24^th Annual Needham Virtual Healthcare Conference, being held from April 7^th to April 10^th, and will be holding one-on-one meetings with investors registered with the conference. The presentation will be webcast live at 3:00 p.m. ET on Thursday April 10^th. The presentation will also be archived in the Investors section of the Company’s website.

Event:	24th Annual Needham Virtual Healthcare Conference
Date:	Thursday, April 10, 2025
Time:	3:00 p.m. ET
Webcast:	Available here

About Myomo

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. It is currently the only marketed device in the U.S. that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Burlington, Massachusetts, with sales and clinical professionals across the U.S. and representatives internationally. For more information, please visit www.myomo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250331633659/en/

Myomo:

ir@myomo.com

Alliance Advisors IR:

Tirth T. Patel

tpatel@allianceadvisors.com

212-201-6614

Source: Myomo, Inc.

FAQ

When is Myomo (MYO) presenting at the Needham Healthcare Conference?

Myomo will present on Thursday April 10th at 3:00 p.m. ET during the 24th Annual Needham Virtual Healthcare Conference.

How can investors watch Myomo's (MYO) Needham Conference presentation?

The presentation will be available via live webcast and will be archived in the Investors section of Myomo's website.

Which Myomo (MYO) executives are participating in the Needham Healthcare Conference?

Paul Gudonis, President and CEO, and David Henry, CFO, will present and conduct one-on-one meetings with investors.

What type of investors can meet with Myomo (MYO) management at the Needham Conference?

Only investors who are registered with the conference can participate in one-on-one meetings with Myomo management.

What is the duration of the Needham Healthcare Conference where Myomo (MYO) is presenting?

The conference runs from April 7th to April 10th.